Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance

Author:

Nissen Steven E.1,Stroes Erik2,Dent-Acosta Ricardo E.3,Rosenson Robert S.4,Lehman Sam J.5,Sattar Naveed6,Preiss David7,Bruckert Eric8,Ceška Richard9,Lepor Norman10,Ballantyne Christie M.11,Gouni-Berthold Ioanna12,Elliott Mary3,Brennan Danielle M.1,Wasserman Scott M.3,Somaratne Ransi3,Scott Rob3,Stein Evan A.13,

Affiliation:

1. Cleveland Clinic, Cleveland, Ohio

2. University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands

3. Amgen Inc, Thousand Oaks, California

4. School of Medicine at Mount Sinai, New York, New York

5. Flinders University, Bedford Park, SA, Australia

6. University of Glasgow, Glasgow, United Kingdom

7. Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom

8. University Hospital of Paris 6, Paris, France

9. Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic

10. David Geffen School of Medicine at the University of California, Los Angeles

11. Baylor College of Medicine, Houston, Texas

12. Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany

13. Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3